{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:59:04Z","timestamp":1793383144012,"version":"4.5.0"},"reference-count":67,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: Urinary tract infections (UTIs) are among the most common bacterial infections in children and represent a leading indication for antibiotic prescribing across inpatient, emergency department, and outpatient settings. Despite the availability of multiple international guidelines, prescribing practices for pediatric UTI frequently deviate from evidence-based recommendations in antibiotic selection, route of administration, and duration of therapy. These suboptimal practices contribute to the emergence of resistant uropathogens, including extended-spectrum \u03b2-lactamase-producing organisms, and highlight the need for a comprehensive stewardship approach specific to this population. Methods: A literature search was performed using PubMed and MEDLINE from January 2000 to May 2026 using the following search terms: urinary tract infection, children, pediatrics, antibiotic stewardship, antimicrobial resistance, diagnosis, treatment, duration, prophylaxis, and intravenous-to-oral transition. Thirteen active international guidelines published between 2011 and 2025 were identified and evaluated with specific emphasis on the integration of antibiotic stewardship principles. Clinical trials, systematic reviews, meta-analyses, and quality improvement studies addressing stewardship-relevant outcomes in pediatric UTI were included. Case reports were excluded. Results: Comparative analysis of 13 international UTI treatment guidelines demonstrated substantial variation in diagnostic criteria, treatment duration, and prophylaxis recommendations, with most guidelines predating the SCOUT, STOP, and INDI-UTI randomized controlled trials. Diagnostic stewardship interventions targeting urine collection methods, urinalysis-guided treatment decisions, and avoidance of antibiotic treatment for asymptomatic bacteriuria represented high-impact opportunities to reduce unnecessary antibiotic exposure. Oral antibiotic therapy was as effective as intravenous therapy for most children with pyelonephritis, and early intravenous-to-oral transition was supported by consistent randomized controlled trial evidence. A 5-day oral course may be reasonable for uncomplicated febrile UTI in children demonstrating clinical improvement, supported by the STOP trial, although the SCOUT trial did not meet its noninferiority margin despite a low absolute failure rate; 3 to 5 days was appropriate for uncomplicated cystitis. Antibiotic prophylaxis was not indicated in children with a normal urinary tract following a first febrile UTI and should be reserved for specific high-risk subgroups, with nitrofurantoin as the preferred agent. Formal antibiotic stewardship programs combining prospective audit and feedback, electronic health record integration, and prescriber education demonstrated measurable improvements in prescribing appropriateness for pediatric UTI. Gepotidacin, a first-in-class oral antibiotic approved in 2025 for uncomplicated UTI in female patients aged 12 years and older and weighing at least 40 kg, represented a limited option for eligible adolescents with resistant infections. Conclusions: Antibiotic stewardship for pediatric UTI addresses the full clinical pathway from diagnostic stewardship through prophylaxis rationalization. Evidence-based interventions targeting urine collection, urinalysis-guided decision-making, early intravenous-to-oral transition, duration optimization, and selective prophylaxis use can collectively reduce unnecessary antibiotic exposure without compromising patient outcomes. A dedicated stewardship-oriented pediatric UTI guideline, standardized resistance surveillance, and multicenter stewardship program evaluations with patient-centered outcomes are critical research priorities.<\/jats:p>","DOI":"10.3390\/antibiotics15070645","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:11:57Z","timestamp":1782785517000},"page":"645","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antibiotic Stewardship in Pediatric Urinary Tract Infections: Current Evidence and Practical Strategies"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8817-6243","authenticated-orcid":false,"given":"Manar O.","family":"Lashkar","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milap C.","family":"Nahata","sequence":"additional","affiliation":[{"name":"Institute of Therapeutic Innovations and Outcomes, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA"},{"name":"College of Medicine, The Ohio State University, 500 West 12th Ave., Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(20)30676-0","article-title":"Urinary tract infections in children","volume":"395","author":"Tullus","year":"2020","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/ua.ua_147_22","article-title":"Urinary tract infection in children: A narrative review of clinical practice guidelines","volume":"15","author":"Alsaywid","year":"2023","journal-title":"Urol. Ann."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1542\/pir.2023-006017","article-title":"Urinary tract infections in children","volume":"45","author":"Marsh","year":"2024","journal-title":"Pediatr. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.euf.2017.09.013","article-title":"Urinary tract infection in children: Management in the era of antibiotic resistance\u2014A pediatric urologist\u2019s view","volume":"3","author":"Kutasy","year":"2017","journal-title":"Eur. Urol. Focus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.pcl.2022.07.003","article-title":"Urinary tract infection in children","volume":"69","author":"Hansson","year":"2022","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/hpeds.2024-007756","article-title":"Antibiotic appropriateness for urinary tract infections in children","volume":"14","author":"Dantas","year":"2024","journal-title":"Hosp. Pediatr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/PEC.0000000000001780","article-title":"Antibiotic prescription practice for pediatric urinary tract infection in a tertiary center","volume":"37","author":"Alghounaim","year":"2021","journal-title":"Pediatr. Emerg. Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.12788\/jhm.3538","article-title":"Opportunities for stewardship in the transition from intravenous to enteral antibiotics in hospitalized pediatric patients","volume":"16","author":"Cotter","year":"2021","journal-title":"J. Hosp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"363.e1","DOI":"10.1016\/j.jpurol.2022.03.027","article-title":"Continuous antibiotic prophylaxis in isolated prenatal hydronephrosis","volume":"18","author":"Chamberlin","year":"2022","journal-title":"J. Pediatr. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"El Zein, Z., Boutros, C.F., El Masri, M., El Tawil, E., Sraj, M., and Salameh, Y. (2025). The challenge of multidrug resistance in hospitalized pediatric patients with urinary tract infections. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1570405"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"129.e1","DOI":"10.1016\/j.jpurol.2022.10.020","article-title":"Risk factors for community acquired pediatric urinary tract infection with extended-spectrum-\u03b2-lactamase Escherichia coli\u2014A case-control study","volume":"19","author":"Collingwood","year":"2023","journal-title":"J. Pediatr. Urol."},{"key":"ref_12","first-page":"20499361241282824","article-title":"Impact of an antibiotic stewardship program on adherence to antibiotic prescription in children admitted with urinary tract infection","volume":"11","author":"Brigadoi","year":"2024","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/hpeds.2023-007561","article-title":"Reducing antibiotic duration for uncomplicated UTI in the pediatric emergency department","volume":"14","author":"Kooner","year":"2024","journal-title":"Hosp. Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/ice.2025.59","article-title":"Discharge antibiotic prescribing at children\u2019s hospitals with established antimicrobial stewardship programs","volume":"46","author":"Same","year":"2025","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1097\/INF.0000000000004790","article-title":"Guidelines for complicated urinary tract infections in children: A review by the European Society for Pediatric Infectious Diseases","volume":"44","author":"Bryant","year":"2025","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_16","unstructured":"European Association of Urology\/European Society for Paediatric Urology (2025). Paediatric Urology Guidelines, Section 3.10: Urinary Tract Infections in Children, EAU\/ESPU. Available online: https:\/\/uroweb.org\/guidelines\/paediatric-urology."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Trautner, B.W., Cort\u00e9s-Penfield, N.W., Gupta, K., Hirsch, E.B., Horstman, M., Moran, G.J., Colgan, R., O'Horo, J.C., Ashraf, M.S., and Connolly, S. (2025). Clinical practice guideline by the Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections. Clin. Infect. Dis., ciaf460.","DOI":"10.1093\/cid\/ciaf459"},{"key":"ref_18","unstructured":"National Institute for Health and Care Excellence (2022). Urinary Tract Infection in Under 16s: Diagnosis and Management; NICE Guideline NG224; amended November 2025, NICE. Available online: https:\/\/www.nice.org.uk\/guidance\/ng224."},{"key":"ref_19","unstructured":"National Institute for Health and Care Excellence (2024). Urinary Tract Infection (Recurrent): Antimicrobial Prescribing; NICE Guideline NG112; updated December 2024, NICE. Available online: https:\/\/www.nice.org.uk\/guidance\/ng112."},{"key":"ref_20","first-page":"132","article-title":"Update of the Spanish clinical practice guideline for urinary tract infection in infants and children","volume":"101","year":"2024","journal-title":"An. Pediatr. (Engl. Ed.)"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00467-023-06173-9","article-title":"Evidence-based clinical practice guideline for management of urinary tract infection and primary vesicoureteric reflux","volume":"39","author":"Hari","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00431-020-03714-4","article-title":"Swiss consensus recommendations on urinary tract infections in children","volume":"180","author":"Buettcher","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpam.2021.03.001","article-title":"Diagnosis and management of community-acquired urinary tract infection in infants and children: Clinical guidelines endorsed by the Saudi Pediatric Infectious Diseases Society (SPIDS)","volume":"8","author":"Albarrak","year":"2021","journal-title":"Int. J. Pediatr. Adolesc. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jiac.2021.07.014","article-title":"Asian guidelines for urinary tract infection in children","volume":"27","author":"Yang","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jamapediatrics.2023.1979","article-title":"Short-course therapy for urinary tract infections in children: The SCOUT randomized clinical trial","volume":"177","author":"Zaoutis","year":"2023","journal-title":"JAMA Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1473-3099(25)00075-1","article-title":"Efficacy and safety of individualised versus standard 10-day antibiotic treatment in children with febrile urinary tract infection (INDI-UTI): A pragmatic, open-label, multicentre, randomised, controlled, non-inferiority trial in Denmark","volume":"25","author":"Sethi","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/apa.17546","article-title":"Short- versus standard-course antimicrobial therapy for children with urinary tract infection: A meta-analysis","volume":"114","author":"Mueller","year":"2025","journal-title":"Acta Paediatr."},{"key":"ref_28","first-page":"1","article-title":"Shorter treatments for (febrile) urinary tract infections: Are we there?","volume":"14","year":"2025","journal-title":"Transl. Pediatr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1542\/peds.2011-1330","article-title":"Urinary tract infection: Clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months","volume":"128","author":"Roberts","year":"2011","journal-title":"Pediatrics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/apa.14988","article-title":"Updated Italian recommendations for the diagnosis, treatment and follow-up of the first febrile urinary tract infection in young children","volume":"109","author":"Ammenti","year":"2020","journal-title":"Acta Paediatr."},{"key":"ref_32","first-page":"821","article-title":"Management of asymptomatic bacteriuria in children","volume":"64","author":"Dahiya","year":"2018","journal-title":"Can. Fam. Physician"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1007\/s00247-023-05771-x","article-title":"Conflicting views of physicians and surgeons concerning pediatric urinary tract infection: A comparative review","volume":"53","author":"Hewitt","year":"2023","journal-title":"Pediatr. Radiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2023062598","DOI":"10.1542\/peds.2023-062598","article-title":"Short oral antibiotic therapy for pediatric febrile urinary tract infections: A randomized trial (STOP trial)","volume":"153","author":"Montini","year":"2024","journal-title":"Pediatrics"},{"key":"ref_35","first-page":"CD001534","article-title":"Long-term antibiotics for preventing recurrent urinary tract infection in children","volume":"4","author":"Williams","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e2024066758","DOI":"10.1542\/peds.2024-066758","article-title":"Prophylaxis options in children with a history of recurrent urinary tract infections: A systematic review","volume":"154","author":"Gkiourtzis","year":"2024","journal-title":"Pediatrics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.acap.2023.06.023","article-title":"Clinical course of children 1 to 24 months old with positive urine cultures without pyuria","volume":"24","author":"Wang","year":"2024","journal-title":"Acad. Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1177\/00099228251363029","article-title":"Antibiotic stewardship in the emergency department following negative urine cultures for treated UTI","volume":"64","author":"Kieffer","year":"2025","journal-title":"Clin. Pediatr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ucl.2024.06.004","article-title":"Pediatric urinary tract infections","volume":"51","author":"Belko","year":"2024","journal-title":"Urol. Clin. N. Am."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11096-021-01318-y","article-title":"Co-amoxiclav as empiric treatment of UTI in children: Importance of surveillance in ensuring optimal empiric treatment choice","volume":"44","author":"Trayer","year":"2022","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e20162706","DOI":"10.1542\/peds.2016-2706","article-title":"The use of systemic and topical fluoroquinolones","volume":"138","author":"Jackson","year":"2016","journal-title":"Pediatrics"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kimberlin, D.W., Banerjee, R., Barnett, E.D., Lynfield, R., and Sawyer, M.H. (2024). Red Book: 2024\u20132027 Report of the Committee on Infectious Diseases, American Academy of Pediatrics. [33rd ed.].","DOI":"10.1542\/9781610027373"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1345\/aph.18146","article-title":"Clinical use of fluoroquinolones in children","volume":"34","author":"Alghasham","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(23)02196-7","article-title":"Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): Two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials","volume":"403","author":"Wagenlehner","year":"2024","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/jac\/dkad131","article-title":"A multicentre, retrospective audit of fosfomycin use for urinary tract infections in Australian children and adolescents","volume":"78","author":"Purcell","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/cid\/ciz181","article-title":"Fosfomycin for injection (ZTI-01) versus piperacillin-tazobactam for the treatment of complicated urinary tract infection including acute pyelonephritis: ZEUS, a phase 2\/3 randomized trial","volume":"69","author":"Kaye","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40272-025-00685-7","article-title":"Ceftazidime\/avibactam for the treatment of infections in children: A case series of real-world use","volume":"27","author":"Epalza","year":"2025","journal-title":"Paediatr. Drugs"},{"key":"ref_48","first-page":"241","article-title":"Evaluation of outpatient antibiotic prescribing for urinary tract infection in pediatric patients ages 2 months to 18 years","volume":"28","author":"Lee","year":"2023","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_49","first-page":"228","article-title":"Accuracy of antibiotic prescription dosing for urinary tract infections in a regional pediatric ambulatory care setting","volume":"27","author":"Mannix","year":"2022","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.104.1.79","article-title":"Oral versus initial intravenous therapy for urinary tract infections in young febrile children","volume":"104","author":"Hoberman","year":"1999","journal-title":"Pediatrics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/bmj.39244.692442.55","article-title":"Antibiotic treatment for pyelonephritis in children: Multicentre randomised controlled non-inferiority trial","volume":"335","author":"Montini","year":"2007","journal-title":"BMJ"},{"key":"ref_52","first-page":"CD003772","article-title":"Antibiotics for acute pyelonephritis in children","volume":"7","author":"Strohmeier","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e1160","DOI":"10.1542\/peds.2009-2948","article-title":"Length of inpatient stay and ambiguity of antibiotic prescribing for children with urinary tract infections","volume":"126","author":"Brady","year":"2010","journal-title":"Pediatrics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1542\/peds.2011-0814","article-title":"Randomized trial of oral versus sequential IV\/oral antibiotic for acute pyelonephritis in children","volume":"129","author":"Bocquet","year":"2012","journal-title":"Pediatrics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jpids\/pis054","article-title":"Impact of a prospective-audit-with-feedback antimicrobial stewardship program at a children\u2019s hospital","volume":"1","author":"Newland","year":"2012","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/1060028019900650","article-title":"Association of antibiotic treatment duration with recurrence of uncomplicated urinary tract infection in pediatric patients","volume":"54","author":"Afolabi","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/PEC.0000000000002868","article-title":"Opportunities for antibiotic reduction in pediatric patients with urinary tract infection after discharge from the emergency department","volume":"39","author":"Hawkins","year":"2023","journal-title":"Pediatr. Emerg. Care"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"RIVUR Trial Investigators, Hoberman, A., Greenfield, S.P., Mattoo, T.K., Keren, R., Mathews, R., Pohl, H.G., Kropp, B.P., Skoog, S.J., and Nelson, C.P. (2014). Antimicrobial prophylaxis for children with vesicoureteral reflux. N. Engl. J. Med., 370, 2367\u20132376.","DOI":"10.1056\/NEJMoa1401811"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa0902295","article-title":"Antibiotic prophylaxis and recurrent urinary tract infection in children","volume":"361","author":"Craig","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/ciac104","article-title":"Antibiotic stewardship strategies and their association with antibiotic overuse after hospital discharge: An analysis of the Reducing Overuse of Antibiotics at Discharge (ROAD) Home Framework","volume":"75","author":"Vaughn","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_61","first-page":"39","article-title":"Uncomplicated urinary tract infection in ambulatory primary care pediatrics: Are we using antibiotics appropriately?","volume":"24","author":"Le","year":"2019","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.euros.2022.08.009","article-title":"Molecular diagnostic methods versus conventional urine culture for diagnosis and treatment of urinary tract infection: A systematic review and meta-analysis","volume":"44","author":"Douglass","year":"2022","journal-title":"Eur. Urol. Open Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/cid\/ciac738","article-title":"Sulopenem or ciprofloxacin for the treatment of uncomplicated urinary tract infections in women: A phase 3, randomized trial","volume":"76","author":"Dunne","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"EVIDoa2400414","DOI":"10.1056\/EVIDoa2400414","article-title":"Sulopenem versus amoxicillin\/clavulanate for the treatment of uncomplicated urinary tract infection","volume":"4","author":"Puttagunta","year":"2025","journal-title":"NEJM Evid."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/14787210.2021.1951705","article-title":"Antimicrobial resistance in low- and middle-income countries: Current status and future directions","volume":"20","author":"Sulis","year":"2022","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1017\/ash.2024.35","article-title":"The challenges of implementing infection prevention and antimicrobial stewardship programs in resource-constrained settings","volume":"4","author":"Abbas","year":"2024","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00345-024-05145-4","article-title":"Artificial intelligence and machine learning applications in urinary tract infections identification and prediction: A systematic review and meta-analysis","volume":"42","author":"Shen","year":"2024","journal-title":"World J. Urol."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/645\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:16:32Z","timestamp":1782792992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["antibiotics15070645"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15070645","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]}}}